Dr. Carey Anders on Exclusion of Patients With Brain Metastases From Clinical Trials

Carey Anders, MD, assistant professor for the Department of Medicine, Division of Hematology and Oncology, UNC Chapel Hill, discusses the exclusion of patients with breast cancer who have developed brain metastases from clinical trials.

Carey Anders, MD, assistant professor for the Department of Medicine, Division of Hematology and Oncology, UNC Chapel Hill, discusses the exclusion of patients with breast cancer who have developed brain metastases from clinical trials. Anders cites one major frustration with this exclusion being that some of the drugs being tested in clinical trials may be able to penetrate into the central nervous system.